Highly customized biocatalysts can transform API manufacturing processes by eliminating steps, increasing yield, and reducing solvent usage and waste. Explore novel approaches that benefit the triple bottom line – social, environmental, and financial.

When manufacturing RNA for therapeutic applications, the process ideally delivers high yields and minimizes unwanted byproducts, while being economically sound. Engineered enzymes can overcome the particular obstacles faced in the production of quality RNA at commercial scale.